David Pariser
Dermatology · Norfolk, VANPI 1417050717
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $213,738 of the $260,607 with a category attached, or 82.0%. It is spread thinly across 38 manufacturers, the largest accounting for just 14.8%. Reporting peaked in 2019 at $96,464 and has fallen 89.9% since, to $9,753 in 2025. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 484 payments — averaging $538.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$39K
- LEO Pharma Inc.$28K
- Sanofi$26K
- AbbVie$24K
- E.r. Squibb & Sons, L.L.C.$18K
- Johnson & Johnson$17K
- plus $108K from 32 others
Across 1,811 payments — averaging $3758.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.5M
- Eli Lilly$966K
- Regeneron$828K
- Novartis$647K
- Dermira, Inc.$525K
- Pfizer$439K
- plus $1.9M from 24 others
What the payments were for
- Consulting fees$213,73882%
- Speaking & faculty fees$19,2107%
- Travel & lodging$15,9556%
- Food & beverage$11,4864%
- Education$2180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 32 | $38,532 |
| LEO Pharma Inc. | 20 | $28,308 |
| Sanofi | 17 | $26,278 |
| AbbVie | 118 | $23,894 |
| E.r. Squibb & Sons, L.L.C. | 43 | $18,310 |
| Johnson & Johnson | 28 | $17,290 |
| Novartis | 22 | $15,278 |
| Lilly USA, LLC | 57 | $13,182 |
| Boehringer Ingelheim | 8 | $12,180 |
| Janssen Scientific Affairs, LLC | 18 | $10,957 |
| UCB, Inc. | 11 | $9,857 |
| Biofrontera Inc. | 18 | $9,205 |
| LEO Pharma AS | 4 | $6,184 |
| Dermira, Inc. | 9 | $4,531 |
| Mindera Corp | 3 | $4,125 |
| Pfizer | 16 | $3,624 |
| Amgen | 11 | $2,775 |
| Sensus Healthcare, Inc. | 1 | $2,500 |
| Sanofi-aventis U.S. LLC | 7 | $2,229 |
| Janssen Global Services, LLC | 3 | $2,111 |
| Astrazeneca UK Limited | 1 | $1,800 |
| Eli Lilly | 1 | $1,600 |
| Verrica Pharmaceuticals Inc. | 2 | $1,305 |
| Celltrion, Inc. | 2 | $1,200 |
| Almirall LLC | 4 | $1,033 |
| Biogen | 1 | $725 |
| Aurobindo Pharma USA, Inc. | 1 | $700 |
| Arcutis Biotherapeutics, Inc. | 1 | $178 |
| Incyte Corporation | 4 | $173 |
| Sun Pharmaceutical Industries Inc. | 6 | $166 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $157 |
| Bristol Myers Squibb | 1 | $51 |
| Journey Medical Corporation | 1 | $42 |
| Sandoz | 2 | $33 |
| Strata Skin Sciences, Inc. | 2 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Springworks Therapeutics, Inc. | 1 | $20 |
| Regeneron | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$260,607 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.
Other dermatology in Norfolk
- Jonathan SchreiberNorfolk$330K
- Abby van VoorheesNorfolk$64K
- Molly SmithNorfolk$11K
- Robert PariserNorfolk$10K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.